Evidence map›Paper›PMID 32754787›Full record

ArticleClinical oral investigations2021

Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.

Steffen Spoerl, Michael Gerken, Andreas Mamilos, René Fischer, Stefanie Wolf, Felix Nieberle, Christoph Klingelhöffer, Johannes K Meier, Silvia Spoerl, Tobias Ettl and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical oral investigations, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Depth of Invasion, Lymphovascular Invasion, and Perineural Invasion as Predictors of Neck Node Metastasis in Early Oral Cavity Cancers.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Steffen SpoerlDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, D-93042, Regensburg, Germany.
Michael GerkenTumor Center-Institute for Quality Management and Health Services Research, University of Regensburg, Regensburg, Germany.
Andreas MamilosInstitute of Pathology, University Regensburg, Regensburg, Germany.
René FischerDepartment of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany.
Stefanie WolfDepartment of Otorhinolaryngology, St. Elisabeth Hospital Straubing, Straubing, Germany.
Felix NieberleRegensburg Center for Interventional Immunology, University Hospital Regensburg, Regensburg, Germany.
Christoph KlingelhöfferDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, D-93042, Regensburg, Germany.
Johannes K MeierDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, D-93042, Regensburg, Germany.
Silvia SpoerlDepartment of Internal Medicine 5-Hematology/Oncology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Tobias EttlDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, D-93042, Regensburg, Germany.
Torsten E ReichertDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, D-93042, Regensburg, Germany.
Gerrit SpanierDepartment of Cranio-Maxillofacial Surgery, University Hospital Regensburg, D-93042, Regensburg, Germany. gerrit.spanier@ukr.de.ORCID http://orcid.org/0000-0002-0226-7580

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesRecently, multiple studies addressed the importance of lymph node ratio (LNR) in specifying patients' risk of disease recurrence in various malignancies. The present study examines the prognostic significance of LNR in predicting outcome of oral squamous cell carcinoma (OSCC) patients after surgical treatment with curative intent.

methodsHere, we describe a retrospective population-based cohort with 717 patients previously diagnosed with OSCC. Histopathologically verified lymph node metastasis was diagnosed in 290 patients. Among these patients, we evaluated the impact of LNR on overall survival (OAS) and recurrence-free survival (RFS) in uni- as well as multivariate analysis.

resultsA median cutoff (0.055) in LNR was found to significantly predict outcome in OSCC patients. Five-year OAS was 54.1% in patients with a low LNR, whereas a high LNR was associated with a 5-year OAS of 33.3% (p < 0.001). Similar results were detected for RFS with a 5-year survival rate of 49.8% (LNR low) and 30.3% (LNR high) (p = 0.002). Results were confirmed in multivariate Cox regression which substantiated the importance of LNR in predicting survival in OSCC patients.

conclusionsLNR was shown to be an independent prognostic factor for outcome of OSCC in a population-based cohort in uni- as well as multivariate analysis. Hereby, a LNR ≥ 0.055 predicted a shorter OAS and RFS in our cohort. CLINICAL RELEVANCE: Besides established histopathological factors, LNR can be used as a reliable predictor of outcome in OSCC and might therefore be further applied in evaluating adjuvant treatment after resection in curative intention.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsCohort StudiesHumansLymph Node ExcisionLymph Node RatioLymph NodesNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRetrospective StudiesSquamous Cell Carcinoma of Head and NeckLymph node densityLymph node ratioOral squamous cell carcinomaRecurrenceSurvival

Identifiers

PMID32754787
PMCPMC7966215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.